HCPCS Level II › J codes J2711 Inj neostigmin/glycopyrrolatInjection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
Medicare coverage: Carrier judgment Status: active (October 2026 file) Medically Unlikely Edits (effective October 1, 2026) Practitioner: max 60 units per day (clinical), rationale: Prescribing Information Outpatient hospital: max 60 units per day (clinical), rationale: Prescribing Information DME supplier: max 60 units per day (clinical), rationale: Prescribing Information Medicare pricing for J2711 Physician Fee Schedule (CY 2026, RVU26D) Status E: excluded from the PFS by regulation.
Payer policies and prior authorization for J2711 Payer coverage policies that name J2711 J2711 appears in 1 coverage policy from Aetna.
Payer Policy Role in policy Reviewed Document Aetna Injectable Medications (0020) listed, no stance (range J2550-J3520) Mar 5, 2026 payer document
Medicaid fee-for-service AZ: $0.71 (outpatient_hospital), effective Jan 1, 2026 IN: $0.63 (professional, Advanced Practice Nurse (85%), non-facility), effective Jan 1, 2026 KS: $0.53 (default, Exempt Physician), effective Jan 1, 2026 MS: $0.71 (comprehensive), effective Jan 1, 2026 NE: $0.76 (injectables), effective Jul 1, 2026 OK: $1.18 (physician, non-facility), effective Jul 1, 2026 TX: $0.72 (nurse_practitioner_clinical_nurse_specialist, Nurse Practitioner/Clinical Nurse Specialist, non-facility), effective Jan 1, 2026 VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026 WA: $0.71 (professional_administered_drugs), effective Jul 1, 2026 WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026 From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.